Press Releases April 5, 2026 08:00 PM

USCB Financial Holdings, Inc. to Announce First Quarter 2026 Results

USCB Financial Holdings to Report Q1 2026 Earnings and Host Conference Call

By Leila Farooq
Share
Twitter Reddit Facebook LinkedIn
USCB

USCB Financial Holdings, Inc., a Nasdaq-listed bank holding company, announced it will release its first quarter 2026 financial results on April 23, 2026, followed by a conference call with executive leadership to discuss performance. The company operates U.S. Century Bank, a major community bank in Florida.

USCB Financial Holdings, Inc. to Announce First Quarter 2026 Results
USCB
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • USCB Financial Holdings will announce Q1 2026 results after market close on April 23, 2026.
  • A conference call featuring CEO Luis de la Aguilera and other executives is scheduled for April 24, 2026.
  • USCB Financial Holdings operates U.S. Century Bank, one of Florida's largest community banks, with a strong 5-star BauerFinancial rating.

MIAMI, April 06, 2026 (GLOBE NEWSWIRE) -- USCB FINANCIAL HOLDINGS, INC. (the “Company”) (NASDAQ: USCB) will report financial results for the quarter ended March 31, 2026 after the market closes on Thursday, April 23, 2026.

A conference call to discuss quarterly results will also be held with Chairman, President, and CEO, Luis de la Aguilera, Chief Financial Officer, Robert Anderson, and Chief Credit Officer, William Turner, details which are provided below.

Live Conference Call and Audio Webcast

Date: Friday, April 24, 2026
Time: 11:00am Eastern Time
Dial-in: (833) 816-1416 (toll free in the U.S.)
Passcode: USCB Financial Holdings Call

A live audio webcast of the call will be available with the press release and slides on the investor relations page of the Company's website at https://investors.uscenturybank.com/. Please allow extra time prior to the call to visit the site and download the streaming media software required to listen to the internet broadcast.

A replay of the webcast will be archived on the investor relations page shortly after the conference call has ended.

About USCB Financial Holdings, Inc.

USCB Financial Holdings, Inc. is the bank holding company for U.S. Century Bank. Established in 2002, U.S. Century Bank is one of the largest community banks headquartered in Miami, and one of the largest community banks in the state of Florida. U.S. Century Bank is rated 5-Stars by BauerFinancial, the nation’s leading independent bank rating firm. U.S. Century Bank offers customers a wide range of financial products and services and supports numerous community organizations, including the Greater Miami Chamber of Commerce, the South Florida Hispanic Chamber of Commerce, and ChamberSouth. For more information or to find a U.S. Century Bank banking center near you, please call (305) 715-5200 or visit www.uscentury.com.

Contacts:

Investor Relations
[email protected]

Media Relations
Martha Guerra-Kattou
[email protected]


Risks

  • The article does not disclose financial performance details, leaving uncertainty about earnings outcomes and potential market impact.
  • Community bank sector faces interest rate and credit risk environment uncertainties that could influence USCB's results.
  • Market reactions depend on financial results and outlook provided during the upcoming conference call, which could introduce volatility.

More from Press Releases

Agios Showcases RISE UP Phase 3 Results at EHA 2026 Plenary Session Reinforcing Strong Anti-Hemolytic Profile of Mitapivat in Sickle Cell Disease Jun 13, 2026 Rhythm Pharmaceuticals Presents Positive Interim Six-month Data from Phase 2 Trial of Setmelanotide in Patients with Prader-Willi Syndrome (PWS) at ENDO 2026 Jun 13, 2026 Intellia Therapeutics Reports Additional Positive Phase 3 Results for Lonvoguran Ziclumeran (lonvo-z) in Patients with Hereditary Angioedema Jun 13, 2026 Arcadia Biosciences (RKDA) Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules Jun 12, 2026 Belite Bio Completes Rolling Submission of New Drug Application to U.S. Food and Drug Administration for Tinlarebant for the Treatment of Stargardt Disease Type 1 Jun 12, 2026